Endogenous ouabain-like factor (OLF) secretion is modulated by nicotinic mechanisms in rat adrenocortical cells.
D000109:Acetylcholine / Q000494:pharmacology; D000157:Aconitine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000302:Adrenal Cortex / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002298:Cardenolides; D004077:Digoxin; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D018738:Hexamethonium / Q000494:pharmacology; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology; D018733:Nicotinic Antagonists / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011978:Receptors, Nicotinic / Q000187:drug effects / Q000378:metabolism*; D012503:Saponins / Q000378:metabolism*
D002298:Cardenolides; D018733:Nicotinic Antagonists; D011978:Receptors, Nicotinic; D012503:Saponins; C034504:digoxin-like factors; C054634:methyllycaconitine; D018738:Hexamethonium; D008464:Mecamylamine; D009538:Nicotine; D004077:Digoxin; D010830:Physostigmine; D000109:Acetylcholine; D000157:Aconitine